Industry · Pharmaceuticals & Biotechnology
Intellectual property for pharma and biotech.
From small molecules and biologics to gene and cell therapies, we support pharma innovators and biotech startups with rigorous patentability, prosecution, lifecycle management and freedom-to-operate work.
Coverage
- Small molecules & formulations
- Biologics, mAbs & biosimilars
- Gene, cell & mRNA therapies
- Diagnostics & companion Dx
Industry overview
The state of innovation in pharmaceuticals & biotechnology.
Innovation trends
mRNA platforms, cell and gene therapies, AI-driven drug discovery and precision medicine are reshaping the pharma IP frontier.
Common IP challenges
Composition-of-matter vs method claims, biosimilar pressure, patent term extensions and complex jurisdictional strategy.
Why IP matters
Patents drive exclusivity, licensing revenue, orange-book listing and defensibility against generics and biosimilars.
Global landscape
US, Europe, China, Japan and India dominate pharma filings; expedited examination and PTA/PTE strategies matter globally.
IP services for pharmaceuticals & biotechnology
A full-stack IP practice, tailored to your sector.
Prior Art Search
PhD-led novelty and prior art searches across 140M+ patent and non-patent records.
Patentability Search
Assess novelty and inventive step before you invest in drafting and filing.
Freedom to Operate
Jurisdiction-scored FTO analyses that de-risk launches and product roadmaps.
Patent Drafting
Specification, claims and figures drafted by domain experts and registered attorneys.
Patent Filing & Prosecution
PCT, national phase and direct filings coordinated across 40+ jurisdictions.
Office Action / FER Response
Strategic responses that preserve claim scope while overcoming examiner rejections.
Patent Landscape Analysis
Editorial-grade landscapes revealing white space, competitors and technology trends.
Patent Portfolio Management
Renewal, pruning, valuation and licensing strategy across the portfolio lifecycle.
Competitive Intelligence
Vendor, filer and inventor competitive maps refreshed on your schedule.
AI-Powered Patent Analytics
Hashi.AI agents accelerate search, mapping and analytics with human review.
Technology areas
Where our pharmaceuticals & biotechnology expertise runs deepest.
Small Molecules
NCEs, formulations, polymorphs, salts and delivery systems.
Biologics
Monoclonal antibodies, fusion proteins and biosimilar strategy.
Gene & Cell Therapy
AAV, CAR-T, gene editing (CRISPR) and cell therapy platforms.
mRNA & Vaccines
mRNA platforms, LNP delivery and novel vaccine modalities.
AI Drug Discovery
Generative chemistry, target ID and clinical trial optimization.
Diagnostics
Companion diagnostics, molecular Dx and liquid biopsy.
Why Hashi IP Solutions
Built for sectors where IP is the moat.
Experienced patent professionals
PhDs, engineers and registered attorneys with deep sector experience.
AI-assisted patent analytics
Hashi.AI accelerates search, mapping and landscape work with human oversight.
Global IP support
Coordinated filings and prosecution across 40+ jurisdictions worldwide.
End-to-end IP lifecycle
Search, drafting, prosecution, analytics, licensing and monitoring under one roof.
Industry-focused expertise
Domain specialists who understand your technology and competitive landscape.
Confidential handling
ISO-aligned processes, NDAs and secure infrastructure for sensitive innovations.
Protect your innovation with confidence
Ready to strengthen your pharmaceuticals & biotechnology IP.
Talk to a Hashi specialist about search, drafting, prosecution, landscape or portfolio strategy for your pharmaceuticals & biotechnology programme.